BIAF
Income statement / Annual
Last year (2024), bioAffinity Technologies, Inc.'s total revenue was $9.36 M,
an increase of 269.68% from the previous year.
In 2024, bioAffinity Technologies, Inc.'s net income was -$9.04 M.
See bioAffinity Technologies, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$9.36 M |
$2.53 M |
$4,803.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$1.74 M
|
$467.00
|
$4,817.00
|
$22,242.00
|
$40,278.00
|
| Gross Profit |
$9.36 M
|
$791,615.00
|
$4,336.00
|
-$4,817.00
|
-$22,242.00
|
-$40,278.00
|
| Gross Profit Ratio |
1
|
0.31
|
0.9
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$1.72 M
|
$1.29 M
|
$1.33 M
|
$1.61 M
|
$1.85 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$2.73 M
|
$880,772.00
|
$994,343.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
-$74,736.00
|
$6.79 M
|
$2.73 M
|
$880,772.00
|
$994,343.00
|
$1.20 M
|
| Other Expenses |
$0.00
|
$249,592.00
|
-$1.87 M
|
$724,928.00
|
-$4.28 M
|
$0.00
|
| Operating Expenses |
-$74,736.00
|
$8.76 M
|
$4.02 M
|
$2.21 M
|
$2.60 M
|
$3.05 M
|
| Cost And Expenses |
-$74,736.00
|
$10.51 M
|
$4.02 M
|
$2.21 M
|
$2.60 M
|
$3.09 M
|
| Interest Income |
$0.00
|
$122,131.00
|
$46,708.00
|
$424.00
|
$1,073.00
|
$2,777.00
|
| Interest Expense |
$0.00
|
$37,125.00
|
$2.53 M
|
$1.00 M
|
$382,171.00
|
$214,834.00
|
| Depreciation & Amortization |
$0.00
|
$249,592.00
|
$10,182.00
|
$4,817.00
|
$22,242.00
|
$40,278.00
|
| EBITDA |
$0.00 |
-$7.63 M |
-$5.61 M |
-$2.20 M |
-$6.86 M |
-$3.05 M |
| EBITDA Ratio |
0
|
-3.01
|
-1167.78
|
0
|
0
|
0
|
| Operating Income Ratio |
1.01
|
-3.15
|
-835.12
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$18.46 M
|
$57,210.00
|
-$4.14 M
|
-$4.12 M
|
-$4.66 M
|
-$212,059.00
|
| Income Before Tax |
-$9.03 M
|
-$7.92 M
|
-$8.15 M
|
-$6.32 M
|
-$7.27 M
|
-$3.30 M
|
| Income Before Tax Ratio |
-0.96
|
-3.13
|
-1697.2
|
0
|
0
|
0
|
| Income Tax Expense |
-$11,650.00
|
$20,993.00
|
$2,459.00
|
$1,950.00
|
$2,750.00
|
$3,200.00
|
| Net Income |
-$9.04 M
|
-$7.94 M
|
-$8.15 M
|
-$6.33 M
|
-$7.27 M
|
-$3.31 M
|
| Net Income Ratio |
-0.97
|
-3.13
|
-1697.71
|
0
|
0
|
0
|
| EPS |
-0.73 |
-0.91 |
-1.81 |
-0.86 |
-0.99 |
-0.45 |
| EPS Diluted |
-0.73 |
-0.91 |
-1.81 |
-0.86 |
-0.99 |
-0.45 |
| Weighted Average Shares Out |
$12.39 M
|
$8.75 M
|
$4.50 M
|
$7.38 M
|
$7.38 M
|
$7.38 M
|
| Weighted Average Shares Out Diluted |
$12.39 M
|
$8.75 M
|
$4.50 M
|
$7.38 M
|
$7.38 M
|
$7.38 M
|
| Link |
|
|
|
|
|
|
